Tocilizumab prescribing criteria for COVID-19 patients

Journal article

Peer reviewed

Ayman M. Al-Qaaneh and Fuad H. Al-Ghamdi

Human vaccines & immunotherapeutics, Vol.17(4), pp.1128-1128

03/04/2021

PMID: 33079613

Abstract

COVID-19

cytokine storm

interleukin 6

monoclonal antibody

SARS-CoV-2

Tocilizumab

1 Record Views

Title: Tocilizumab prescribing criteria for COVID-19 patients
Creators - without role: Ayman M. Al-Qaaneh - Saudi Aramco Medical Services Organization
Fuad H. Al-Ghamdi - Saudi Aramco Medical Services Organization
Publication Details: Human vaccines & immunotherapeutics, Vol.17(4), pp.1128-1128
Publisher: Taylor & Francis
Identifiers: 9915248808331
Academic Unit: Imam Abdulrahman Bin Faisal University
Language: English
Resource Type: Journal article